Author: Olivia Dimmer
-
Understanding the Genomic Complexities of Glioblastoma Tumors
Genetic makeup and structure can shift dramatically across different areas of a single glioblastoma tumor, reveals a Northwestern Medicine study published in Science Advances.
-
New Scoring System Improves Colorectal Cancer Risk Prediction
A newly developed scoring system could enhance risk prediction and guide treatment decisions for colorectal cancer, according to a study published in the Journal of Clinical Oncology.
-
Novel Longcoding RNA May Serve as Therapeutic Target for Prostate Cancer
Northwestern Medicine investigators have discovered that a novel long noncoding RNA, which are usually 200 nucleotides longer than typical RNAs, could serve as a prognostic biomarker and therapeutic target for prostate cancer, according to a recent study published in Science Advances.
-
Discovering New Ways to Recharge T-Cells Fighting Cancer
A pair of recent studies from the laboratory of Bin Zhang, MD, PhD, the Johanna Dobe Professor of Cancer Immunology, have uncovered new details about critical immunological processes that may help improve cancer treatments, according to the findings.
-
Advancing Research and Care at Alzheimer Day
Patients and families joined faculty, students and trainees on May 15 for Alzheimer Day, an annual event hosted by the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease to showcase dementia and aging research conducted throughout Northwestern and bring those discoveries to the community.
-
Celebrating the MD Class of 2025
Feinberg honored the MD Class of 2025 during the medical school’s 166th commencement ceremony held in the Aon Grand Ballroom at Navy Pier on May 19.
-
Body’s Own Cannabinoids May Be Key to Reducing Excessive Fear Responses
Specific cannabinoids produced by the human body may help to quell excessive fear responses in people with post-traumatic stress disorder and anxiety, according to a Northwestern Medicine-led study published in the Journal of Clinical Investigation.
-
New Biomarkers Needed to Evaluate Heart Failure Risk Post-Pregnancy
Biomarkers used to predict heart failure risk in the general population may be ineffective for assessing risk after pregnancies complicated by hypertension or diabetes, according to a study published in JAMA Cardiology.
-
Distinguished Molecular Biologist Delivers 2025 Kimberly Prize Lecture
Esteemed molecular biologist Ron Evans, PhD, known for his groundbreaking discovery of the nuclear receptor superfamily, delivered the third Kimberly Prize in Biochemistry and Molecular Genetics Lecture to a crowded auditorium of Feinberg faculty, staff, fellows and students on April 30.
-
Enzyme Drives Treatment Resistance in Ovarian Cancer
Northwestern Medicine scientists have identified a key driver of chemotherapy resistance in advanced ovarian cancer, according to a study published in the Journal of Clinical Investigation.
